Can Hydrogen Therapy Help Protect Bones in Kidney Disease?
Molecular Hydrogen and the Uremic Skeleton: A Critical Review and Turnover-State-Dependent Redox Hypothesis in CKD-MBD
Research hubs: Endocrine System · Cardiovascular System
- Authors
- Po-Jen Hsiao, Ching-Tsai Hsu, Wen-Fang Chiang, Jenq-Shyong Chan, Li-Yen Huang, Chung-Chi Yang, Kuo-Cheng Lu
- Journal
- Antioxidants
- Year
- 2026
- DOI
- 10.3390/antiox15091137
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- Taiwan
- Health Condition
- Chronic Kidney Disease
- Body System
- Skeletal
TL;DR
People with kidney disease often have weak, fragile bones, and scientists are looking at whether breathing hydrogen gas (yes, really!) could help protect those bones by calming down harmful chemical damage in the body — but so far it's just a promising idea that needs a lot more testing before anyone should try it.
Key Finding
No human study has directly tested molecular hydrogen's effect on bone health in CKD patients; existing evidence is observational and lacks bone-specific measurements, leaving the hypothesis unproven.
Summary
This paper is a critical review — not a new experiment — that examines how molecular hydrogen might affect bone disease in people with chronic kidney disease (CKD). CKD often disrupts the balance between cells that build bone (osteoblasts) and cells that break it down (osteoclasts), partly through oxidative stress (damage caused by unstable molecules called reactive oxygen species). The authors propose that hydrogen's ability to reduce harmful oxidative stress could help protect bone, but they conclude that the effect would likely depend on what type of bone disease a patient has, and that no human studies have actually tested this in bone yet.
Practical Takeaway
This review suggests that hydrogen may theoretically support bone health in certain types of kidney-related bone disease by reducing oxidative stress, but this is based on animal studies and indirect evidence — no clinical trials have tested it. People with CKD should not interpret this as evidence that hydrogen water benefits their bones. The authors themselves call for proper clinical trials before any conclusions can be drawn.
Abstract (excerpt)
Chronic kidney disease-mineral and bone disorder (CKD-MBD) confers a substantial fracture burden that is only partly addressed by therapies targeting phosphate, parathyroid hormone, and vitamin D. Redox dysregulation may represent a complementary mechanism: reactive oxygen species (ROS)…